The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies

BACKGROUND: Relapsed refractory multiple myeloma (RRMM) is a disease that is nonresponsive or progressive on therapy, and although patients can achieve remission, relapse is common. As more treatment options become available for multiple myeloma (MM), it is important to understand patients' exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Crawford, Rebecca, Gries, Katharine S., Valluri, Satish, Fastenau, John, Morrison, Ross, Yeh, Tzu‐Min, Olyslager, Yunsi, Goldberg, Jenna D., Schecter, Jordan M., Jackson, Carolyn C., Deraedt, William, Doward, Lynda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675381/
https://www.ncbi.nlm.nih.gov/pubmed/35168299
http://dx.doi.org/10.1002/cnr2.1603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675381/
https://www.ncbi.nlm.nih.gov/pubmed/35168299
http://dx.doi.org/10.1002/cnr2.1603

Ejemplares similares